Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis

Medicine and Dentistry

• Glutathione 100%
• Endocytosis 100%
• Conjugate 100%
• Chemical Carcinogenesis 100%
• Clathrin 100%
• Neoplasm 33%
• Small Interfering RNA 16%
• Receptor 16%
• Cancer Cell 16%
• Xenograft 16%
• Prostate Cancer 16%
• Carcinogenesis 16%
• Targeted Therapy 16%
• Lung Cancer 16%
• Protein P53 16%
• Kidney Cancer 16%
• Carcinogen 16%
• Topical Drug Administration 16%
• Antisense 16%
• Phorbol Ester 16%
• Dimethylbenz[a]anthracene 16%
• Mutant Protein 16%
• Benzo[a]pyrene 16%
• Skin Carcinogenesis 16%
• Colon Carcinoma 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Glutathione 100%
• Clathrin 100%
• Chemical Carcinogenesis 100%
• Neoplasm 33%
• Receptor 16%
• Mouse Model 16%
• Small Interfering RNA 16%
• Malignant Neoplasm 16%
• Prostate Cancer 16%
• Carcinogen 16%
• Carcinogenesis 16%
• Lung Cancer 16%
• Protein P53 16%
• Nude Mouse 16%
• Mutant Protein 16%
• Kidney Cancer 16%
• Benzo(a)pyrene 16%
• Phorbol Ester 16%
• Dimethylbenz[a]anthracene 16%
• Skin Carcinogenesis 16%
• Colon Carcinoma 16%

Keyphrases

• Clathrin-mediated Endocytosis 100%
• RLIP76 100%
• Chemical Carcinogenesis 100%
• Glutathione-conjugate Transport 100%
• Neoplasia 11%
• Transport Activity 11%
• Small Interfering RNA (siRNA) 5%
• Receptor Signaling 5%
• Prostate Cancer 5%
• Mutant Protein 5%
• Splice Variant 5%
• Lung Cancer 5%
• Cancer Cells 5%
• Ligand-receptor Binding 5%
• Functional Consequences 5%
• Antisense 5%
• Mouse Skin 5%
• Colon Cancer 5%
• Targeted Therapy 5%
• Topical Application 5%
• P53 Activation 5%
• Kidney Cancer 5%
• Benzo(a)pyrene 5%
• Phorbol Ester 5%
• Wnt5a Signaling 5%
• JNK Activation 5%
• Nude Mouse Model 5%
• Pulmonary Carcinogenesis 5%
• Carcinogen 5%
• RalBP1 5%
• Skin Carcinogenesis 5%
• Glutathione Conjugates 5%
• Human Xenografts 5%
• Dimethylbenzanthracene 5%
• P38 Activation 5%